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Introduction: The term dysfunctional breathing (DB) has been introduced to describe patients
who display divergent breathing patterns and have breathing problems that cannot be attrib-
uted to a specific medical diagnosis. Patients with DB are often misdiagnosed as having asthma.
Objectives: To describe patients with DB, five years after a breathing retraining intervention.
Methods: Out of initially 25 patients with DB and 25 age and sex-matched patients with
asthma, 22 patients with DB and 23 patients with asthma (ages 25e78 years) were followed
up after five years. Data were collected from posted self-report questionnaires. Only patients
with DB had received breathing retraining, consisting of information, advice and diaphragmatic
breathing. Patients were evaluated regarding quality of life (SF-36), anxiety, depression, sense
of coherence, hyperventilation, influence on daily life, emergency room (ER) visits, and symp-
toms associated with DB.
Results: Quality of life (SF-36), physical component summary scale (PCS), had improved in
patients with DB from 43 to 47 (p Z 0.03). The number of ER visits had decreased from 18
to 2 in patients with DB (p Z 0.02). Symptoms associated with DB had decreased extensively,
from a mean score of 6.9 to 2.7, on a DB criterion list (p < 0.001). Patients with DB were less
impaired by their breathing problems both in daily life and when exercising (p < 0.001). The
only difference found over time in the asthma group concerned quality of health, bodily pain,
which had deteriorated, from 77 to 68 (p Z 0.049).
Conclusion: This five-year follow-up study indicates that patients with dysfunctional breathing
benefit from breathing retraining.
ª 2011 Elsevier Ltd. All rights reserved.of Physiotherapy, Falu Hospital, SE-791 82 Falun, Sweden. Tel.: þ46 23490895; fax: þ46 23490669.
dalarna.se (C. Hagman).
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Studies indicate that as many as one-third of individuals
with physician-diagnosed asthma in developed countries,
are overdiagnosed and do not actually have asthma.1,2
Markund claims that about 10% of patients diagnosed as
having asthma instead suffer from “functional breathing
disorder”.2 The term dysfunctional breathing (DB) has been
introduced to describe patients who display divergent
breathing patterns3 and have breathing problems that
cannot be attributed to a specific medical diagnosis such as
asthma, chronic obstructive pulmonary disease or sensory
hyper-reactivity.4 Dysfunctional breathing can be associ-
ated with symptoms that may be wrongly attributed to
asthma,5 and individuals with dysfunctional breathing often
remain undiagnosed or are misdiagnosed as having
asthma.2,4,6 Incorrect treatment due to misdiagnosis will
not only have consequences for the patients, but will also
have consequences for health economics, as asthma
medications are often prescribed to patients with breathing
problems but without asthma.2 DB can also occur in asso-
ciation with genuine asthma and other airway diseases7 and
there is a risk that these patients are prescribed excessive
doses of asthma medication.6
There is no consensus about a definition of or a diag-
nostic test for DB.3,4 Van Dixhorn suggests that DB
comprises a wider aspect of respiratory function than
hyperventilation, including breathing pattern and body
awareness.8 Thomas has shown that patients treated for
asthma and with symptoms suggestive of dysfunctional
breathing benefit from physiotherapy-based breathing
retraining with improvements in quality of life and regres-
sion of symptoms.9 The intervention included explanation
of symptoms attributable to abnormal breathing and dia-
phragmatic breathing exercises.9 Hornsveld also claims that
many patients with abnormal breathing patterns benefit
from breathing retraining.10
In a previous descriptive baseline study 25 patients with
DB and 25 patients with well-controlled asthma were
investigated.11 The results indicated that patients with DB
were more disabled because of their condition than
patients with well-controlled asthma. They had poorer
health-related quality of life, were more anxious, hadTable 1 Patient characteristics at baseline (patients with data f
(SD).
DB
(n Z 2
Sex, F/M (n) 18/4
Age (yrs) 48 (13
BMI (kg/m2) 25 (3)
Smokers (n) 0
Ex-smokers (n) 5
Duration of the disorder/disease (yrs) 7 (8)
Asthma medication (n) 14*
ER visits last 12 months (n) 8
Score of the 10-criterion list 7.6 (1
DB Z dysfunctional breathing, BMI Z body mass index, ER Z emergpoorer sense of coherence, higher prevalence of suspected
hyperventilation, more breathing problems and their
breathing problems were more negatively affected by
stress than patients with well-controlled asthma. In addi-
tion, they had had breathing problem for a long time (mean
seven years) before being correctly diagnosed, had often
made emergency room visits and had previously been
treated with ineffective asthma medication.
The aim of this follow-up study was to describe patients
with DB who had received breathing retraining interven-
tions, and were thereafter followed for five years. Describe
possible changes in health-related quality of life, anxiety,
depression, sense of coherence, hyperventilation, influ-
ence on daily life, asthma medication, number of emer-
gency room visits and symptoms associated with DB. The
asthma group was included as a control group and evalu-
ated at baseline and at follow-up, as individuals with DB
often are misdiagnosed as having asthma.MethodsSubjects
In the baseline study, 25 patients who fulfilled the criteria
for dysfunctional breathing (see below), but without
a diagnosis of asthma, and 25 age and sex-matched patients
with well-controlled asthma and no dysfunctional breathing
were examined, included and evaluated at the Lung and
Allergy Outpatient Department in Falun, Sweden.11 The 50
patients fulfilled the following criteria: (i) 16e80 years; (ii)
forced expiratory volume in 1 s (FEV1) and vital capacity
(VC)  80% of predicted value; (iii) resting oxygen
saturation  95%; and (iv) no concomitant disease. All
patients had been non-smokers for at least one year prior to
the study. Patient characteristics at baseline are presented
in Table 1.
The patients gave their informed consent prior to their
inclusion in the study, and the study protocol was approved
by the Ethics Committee of the Medical Faculty of Uppsala
University.rom baseline and follow-up). Number of patients (n) and mean
2)
Asthma
(n Z 23)
p-value
17/6 0.77
) 47 (14) 0.76
26 (3) 0.77
0 e
6 1.0
23 (13) <0.001
23 0.001
4 0.19
.4) 1.3 (0.9) <0.001
ency room, * before inclusion.
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breathing
Patients with breathing problems were examined by
a physician, who confirmed that the patient did not have
asthma or any other respiratory disease. As described
previously,11 the diagnosis of patients with DB was based on
examination by a physician, the presence of a dominant
high costal breathing pattern at rest (observed and assessed
visually by the physician and the physiotherapist) and at
least five out of ten symptoms: (i) difficult inspiratory
breathing; (ii) unable to take deep breaths; (iii) increased
breathing frequency (>16/min); (iv) frequent sighing/
yawning; (v) frequent need to clear the throat; (vi) muscle
and joint tenderness in the upper part of the chest (ster-
nocostal joints and/or intercostal muscles): (vii) hacking
cough; (viii) chest tightness; (ix) sensation of lump in the
throat; and (x) previous or current effects of stress (DB
criterion list).
Patients with asthma
Patients with well-controlled asthma had also been diag-
nosed and examined by a physician. The asthma diagnosis
was based on patients’ history, spirometry before and after
bronchodilators and bronchial challenge testing. They were
considered well-controlled if they were clinically stable,
and if FEV1 and VC were 80% of predicted value. All the
patients with asthma used inhaled steroids, 19 patients had
long-acting beta-2-agonists, 18 patients had short-acting
beta-2-agonists, and 12 patients used oral steroids on
demand. They were included in the study if they did not
have a high costal breathing pattern at rest and fulfilled
fewer than five symptoms from the DB criterion list.
Measurements
At inclusion, patients were investigated and answered five
self-report questionnaires at the Department. After the
patients had been examined by the physician, a physio-
therapist examined them and asked about symptoms
according to the DB criterion list. At the five-year follow-
up, the same five questionnaires plus the DB criterion list
were sent to the patients.
Medical Outcomes Survey Short Form 36 questionnaire
(SF-36) measures general health-related quality of life. The
SF-36 has 8 domains: physical function, role physical, bodily
pain, general health, vitality, social function, role
emotional and mental health. For each domain the score
ranges from 0 to 100 (worst e best).12 The first four
domains constitute the physical component summary scale
(PCS) and the last four the mental component summary
scale (MCS).
Hospital Anxiety and Depression Scale (HADS ) measures
mental health,13 yielding separate scores for anxiety and
depression. The score range in HADS is 0e21, a higher score
indicating poorer mental health.
Sense of Coherence (SOC ). The 29 items (11 compre-
hensibility, 10 manageability and 8 meaningfulness) range
from 29 to 203. The higher the score, the stronger the
SOC.14Nijmegens Symptoms Questionnaire (NQ) is suggestive as
a measure of hyperventilation syndrome. The questionnaire
assesses 16 symptoms associated with abnormal breathing
on a five-point scale (0e4). A score of 24/64 or more is
suggestive of a diagnosis of hyperventilation syndrome.15,16
Influence on daily life, a questionnaire consisting of
items concerning breathing problems and effects of stress
and impact on daily life and on exercise. Most of the
answers were given on a visual analog scale (VAS) (0e10 cm,
where 0 indicated the best value and 10 the worst). Most of
the questions were related to the patient’s experience of
the past two months.
Questions regarding asthma medication and emergency
room visits for breathing problems were also included.
DB criterion list. The criterion list used at baseline
consisted of ten criteria, at follow-up the criterion
“increased breathing frequency” was omitted.Intervention
After inclusion and data collection at baseline, the patients
with DB received one to four individual sessions of physio-
therapist-supervised breathing retraining. The number of
visits was based on the patients’ needs. The first session
lasted for 90 min and the following sessions for 60 min with
1e3 months in between. The sessions consisted of expla-
nation of normal breathing, developing patients’ awareness
of their breathing patterns, and possible effects/symptoms
of an upper chest breathing pattern, “dysfunctional
breathing”. They were taught diaphragmatic breathing in
different body positions: supine, sitting and standing. They
were encouraged to be aware of their breathing patterns
and to practice breathing exercises several times each day,
for example when they were lying in bed, sitting on a bus or
watching television. In addition, the DB group also received
information about their condition from the physician. The
patients with asthma did not receive any physiotherapy
intervention.Statistical analysis
Analyses were undertaken with SPSS version 18.0. Data
were analyzed for statistically significant differences
between the groups using the unpaired t-test and Fisher’s
exact test. For differences within groups over time the
paired t-test, McNemar test and Wilcoxon signed-rank test
were used. Effects were considered significant at p < 0.05.Results
Fifty patients answered the questionnaires at baseline and
45 (90%) at the five-year follow-up. Two patients, one in
each group had died (one of sudden cardiac death and one
of colon cancer) at the time of follow-up, and three
patients (two in the DB group, one in the asthma group) did
not return the questionnaires. Thus, data for 22 (88% of the
original number) patients with DB and 23 (92%) patients
with asthma were analyzed. Results include only patients
who were available at baseline and at follow-up.
1156 C. Hagman et al.Health-related quality of life, and anxiety and
depression
In health-related quality of life (SF-36), the domain
“physical function” had improved in the DB group from 77
to 87 (p Z 0.04) (Table 2). At baseline, the DB group had
significantly lower values in “vitality”, “social functioning”,
“role emotional” and “mental health” (p < 0.05) than the
asthma group. At follow-up, there was no significant
difference considering the domain “role emotional”
between the two groups. The summary measure physical
health (PCS) had improved in the DB group. The summary
measure mental health (MCS) was lower in the DB group
both at baseline and at follow-up than in the asthma group
(p < 0.05) (Table 2). No changes were seen over time in
either of the groups regarding the mean scores for anxiety
and depression (Table 2). At baseline, 13 patients (59%)
with DB had a HADS anxiety scores 8, indicating anxiety,
as compared with 6 patients (26%) in the asthma group
(p Z 0.04). At follow-up there were 11 patients (50%) with
DB, as compared with 3 patients (13%) in the asthma group
(p Z 0.01).Sense of coherence and hyperventilation
Sense of coherence was stable over time in both groups
(Table 2) with lower values in the DB group both at baseline
and at follow-up (p < 0.05). There was a decreased mean
score of the NQ in the DB group (Table 2). At baseline, 13
patients (59%) with DB had an NQ score 24, which indi-
cates suspected hyperventilation, and at follow-up theTable 2 Results of health-related quality of life (SF-36), HA
Coherence (SOC) and Nijmegens Symptoms Questionnaire (NQ). N
DB1
(n Z 22)
DB2
(n Z 22)
p-valu
SF-36
PF 77 (21) 87 (17) 0.04
RP 64 (38) 72 (40) 0.40
BP 66 (27) 63 (25) 0.67
GH 54 (21) 62 (21) 0.12
VT 48 (22) 49 (25) 0.80
SF 70 (27) 71 (25) 0.87
RE 70 (44) 76 (39) 0.55
MH 72 (19) 68 (21) 0.36
PCS 43 (9) 47 (10) 0.03
MCS 43 (13) 42 (13) 0.69
HADS-A 9.3 (4.0) 7.8 (4.9) 0.08
HADS-D 6.0 (2.9) 5.0 (3.1) 0.12
SOC 134 (28) 136 (24) 0.65
NQ 27 (10) 22 (8) 0.03
DB Z dysfunctional breathing, 1 Z at baseline, 2 Z at five-year follo
PF Z physical function, RP Z role physical, BP Z bodily pain, GH Z
emotional, MH Z mental health.
PCS Z physical component summary scale, MCS Z mental componen
Low scores on SF-36 and SOC indicate greater impairment.
High scores on HADS (Hospital Anxiety and Depression Scale) and NQresult was nine patients (41%) (p Z 0.34). The corre-
sponding values (a score 24) for patients with asthma
were four patients (17%) both at baseline and at follow-up.
Influence on daily life
Patients with DB had less breathing problems at follow-up
(p < 0.001) (Table 3). Their breathing problems had less
impact both on daily life and on exercise (p < 0.001), they
were less often off work (p Z 0.02), and their breathing
problems were less affected by stress (p Z 0.03). At
baseline the DB group was more affected by stress than the
asthma group (p < 0.001), but no significant group differ-
ence was found at follow-up. No differences in the preva-
lence of breathing problems were seen over time in the
asthma group (Table 3).
Asthma medication, emergency room visits and
symptoms associated with DB
Before inclusion 14 patients with DB were on asthma medi-
cation. None of the patients with DB had used asthma
medication during the five-year follow-up. The asthma
medication in the asthma group was virtually the same at
baseline and at follow-up. At follow-up, the DB group had
fewer emergency room visits due to breathing problems
during the last 12months, both regarding number of patients
and number of visits. Number of DB patients with emergency
room visits during the last 12months had decreased from 8 to
2 (pZ 0.03) and number of visits had decreased from 18 to 2
(pZ 0.02) (Fig. 1). For theDBgroup, themean scoreof theDBDS anxiety (HADS-A), HADS depression (HADS-D), Sense of
umber of patients (n) and mean (SD).
e Asthma1
(n Z 23)
Asthma2
(n Z 23)
p-value
87 (14) 86 (17) 0.70
74 (37) 85 (27) 0.06
77 (29) 68 (26) 0.049
62 (20) 65 (20) 0.41
63 (23) 63 (19) 0.91
93 (15) 88 (19) 0.09
93 (25) 87 (24) 0.46
82 (15) 82 (16) 0.96
46 (10) 47 (9) 0.74
52 (8) 59 (9) 0.50
5.2 (3.8) 4.5 (3.5) 0.25
3.6 (2.8) 3.4 (2.7) 0.55
155 (18) 160 (15) 0.10
15 (7) 16 (9) 0.91
w-up.
general health, VT Z vitality, SF Z social function, RE Z role
t summary scale.
indicate greater impairment.
Table 3 Breathing problems and the effects of stress, impact on daily life and on exercise measured on a visual analog scale
(with 0 as not at all/never and 10 as very much/very often). All questions, except the last question, relate to the patient’s
experience of the last two months. Number of patients (n) and mean (SD).
DB1
(n Z 22)
DB2
(n Z 22)
p-value Asthma1
(n Z 23)
Asthma2
(n Z 23)
p-value
My breathing problems are negatively affected
by stress
6.7 (2.8) 4.7 (3.4) 0.03 3.5 (2.9) 4.2 (3.3) 0.26
My breathing problems prevent me
from exercising
4.9 (3.4) 2.0 (2.3) <0.001 3.1 (2.7) 3.2 (2.8) 0.80
I experience breathing problems during
exercise
5.0 (3.5) 3.5 (3.2) 0.046 4.3 (2.9) 4.1 (3.2) 0.70
I am afraid of developing breathing problems
during exercise
3.0 (3.6) 2.0 (2.8) 0.17 2.1 (2.1) 2.1 (2.0) 0.89
My breathing problems affect my daily life 6.0 (2.6) 2.0 (2.7) <0.001 2.6 (2.8) 2.8 (2.8) 0.66
I have had breathing problems during the
last two months
7.3 (2.4) 2.9 (3.4) <0.001 3.8 (2.9) 3.4 (3.1) 0.53
I have been off work for my breathing problems
during the last year
1.7 (2.6) 0.2 (0.3) 0.02 1.5 (2.1) 0.8 (0.9) 0.25
DB Z dysfunctional breathing, 1 Z at baseline, 2 Z at five-year follow-up.
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baseline (p < 0.001). At baseline all patients with DB had
a score 5 (inclusion criterion) and at follow-up there were
three patients with a score 5 in the DB group, i.e. fewer
patients with DB had symptoms according to the DB criterion
list (Fig. 2). No differenceswere seen over time in the asthma
group regarding emergency room visits or the mean score on
the DB criterion list.Dysfunctional breathing (DB)
1
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riaDiscussion
This follow-up study suggests that patients with DB had
improved health-related quality of life, and they had fewer
breathing problems both in daily life and in conjunction
with exercise. Their breathing problems were also less
affected by stress. Emergency room visits had decreased
both regarding number of patients and number of visits,
and most of the patients had fewer symptoms according to
the DB criterion list. The only statistically significant
difference found over time in the asthma group was0
2
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Figure 1 Number of emergency room (ER) visits for
breathing problems during the last 12 months. The DB group
had decreased from 18 to 2 (p Z 0.02) and the asthma group
from 9 to 2 (p Z 0.22). DB group (numbers of patients Z 22)
and asthma group (number of patients Z 23), at baseline and
at follow-up. DB Z dysfunctional breathing.regarding quality of health, bodily pain, which had
deteriorated.
These improvements in the DB group could be related to
the treatment they had received, trial involvement effects,
spontaneous improvement of symptoms, or a combination
of these factors. Owing to the design of this study, it cannot
be known if it was the information and the breathing
retraining that led to the improvements. Trial involvement
effects and/or spontaneous improvement of symptoms may
explain some of the improvements. However, the magni-
tude of the improvements, the fact that the patients had0
Baseline Follow-up
Asthma
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Figure 2 Results of the DB criterion list for the DB group
(numbers of patients Z 22) and the asthma group (number of
patients Z 23), at baseline and at five-year follow-up. One
inclusion criterion was that patients with DB had at least five
symptoms from the DB criterion list and patients with asthma
fewer than five symptoms.
1158 C. Hagman et al.had their breathing problems for a mean of seven years
before the intervention and the effects five years after the
intervention make it unlikely this could be the full expla-
nation. There are virtually no data on the natural course of
DB and we therefore cannot rule out that the improvement
in the DB group may have been spontaneous. A study on
patients with sensory hyper-reactivity (SHR) a disorder that
shares some similarities with DB, indicates that SHR does
not improve over time.17 Whether this also is true for DB is
not known.
The patients with DB had improved in physical health
(from SF-36) and they were also less impaired by breathing
problems during exercise (from VAS). It might be difficult
for patients to identify the reasons for their breathing
problems, i.e. whether they are due to exertion, airway
obstruction or abnormal breathing patterns. When symp-
toms remain unexplained fear of illness may become
dominant18 and it may prevent the patients from exer-
cising. The fact that the patients with DB had received
information and explanations about their condition may be
a contributing factor to the improvements regarding their
physical activity. It is of great value to be able to exercise,
as physical activity is an important factor in reducing the
risk of chronic diseases and disabilities.19
There were no improvements in anxiety or depression
either in patients with DB or in patients with asthma in our
study. Thus the decrease of respiratory symptoms in the DB
group is not assumed to be attributed to improvements in
anxiety and depression levels. Studies of patients with
asthma have shown improvements in anxiety and depres-
sion after breathing retraining.20,21 Delgado has shown that
sense of coherence is not related to the physical measures
of symptom severity from the pulmonary function tests, but
to the subjective ratings of breathlessness.22 Although the
sense of coherence was stable over time in this study, the
patients with DB had decreased their frequency of
breathing problems.
The Nijmegen Symptoms Questionnaire cannot be used
alone to diagnose hyperventilation syndrome,16,23 although
it can be used as a screening instrument.16 It can be used as
a quantitative instrument for evaluating the effects of
therapeutic interventions on complaints.23 One limitation
of the questionnaire is that several questions are related to
symptoms such as shortness of breath, pain and constriction
in the chest e symptoms common both to asthma and
dysfunctional breathing.24 There was a decreased mean
score of the NQ in the DB group, but no significant change in
the number of patients with possible hyperventilation (i.e.
a score 24).
The DB group showed decreased frequencies of
breathing problems and their breathing problems were less
affected by stress. Patients with DB had received infor-
mation about their condition, increased awareness of their
breathing pattern, explanations of their symptoms, and
strategies for handling their breathing problems all that
which may have contributed to these improvements. The
patients with DB had had breathing problems for a mean
period of seven years and at baseline they had had several
emergency room visits for breathing problems during the
last 12 months. These results are in accordance with the
findings of other investigators, who showed that having
breathing problems but not being diagnosed and/or notreceiving optimal treatment can increase the health care
consumption.25 When symptoms remain unexplained, fear
of illness may become dominant,18 and this could lead to
increased emergency room visits. Approach to treatment,
to giving the patient insight into the mechanism of his
symptoms can help break the vicious circle.18 At follow-up,
the emergency room visits had decreased extensively both
regarding number of patients and number of visits. There
was also a reduction of symptoms at follow-up, as there was
a decreased score in the DB criterion list.
Breathing retraining for dysfunctional breathing in
asthma has been studied9 as has breathing retraining for
asthma.20,21 In these studies, the physiotherapy-led
breathing retraining included information, diaphragmatic
breathing exercises and elimination of dysfunctional
breathing. The results showed improvements in quality of
life and reduction of symptoms, but no effect on objective
measures of respiratory function. Our study is in line with
other investigations as the intervention had similarities and
there was improvement in quality of life and reduction of
symptoms.
One of the limitations of this study was the small sample
size. However, this study may be considered a pilot study in
order to access important parameters for future random-
ized controlled studies. Another was the fact that we did
not measure carbon dioxide, because a diagnosis of
hyperventilation cannot be confirmed on the basis of the
questionnaire alone.16,23 Therefore, this study does not
show if some of the patients with DB really had hyperven-
tilation with disturbed blood gases. Another disadvantage
was that the DB diagnosis is not yet generally recognized
and there is no existing consensus about a definition of or
a diagnostic test for DB. Therefore, a 10-criteria list was
developed for the baseline study.11 It was drawn up by
asking four specialists in allergology and one physiothera-
pist with experience of patients with DB, to independently
identify the ten most common symptoms in patients with
dysfunctional breathing. These symptoms provided the
basis for the 10-criteria list, which was retrospectively
validated against 51 medical records in patients with a high
costal breathing pattern and breathing problems of
a dysfunctional nature. Agreement between the 10-criteria
list and the medical records was high. There was clinical
consensus in the group that five out of ten criteria gave
a reasonable diagnostic level. The study does not give us
information about possible changes in breathing pattern
five years after the intervention, as the follow-up was
based on posted questionnaires.
Fourteen of the patients with DB were prescribed
asthma medication before inclusion. At follow-up none of
them was using asthma medication or had used asthma
medication during the five-year period. Our results are in
accordance with the findings of other investigators, who
have shown that asthma can be overdiagnosed1,2 and that
some of these patients instead suffer from “dysfunctional
breathing disorders”.2 It is important to identify and diag-
nose patients with DB and it is a condition to be aware of
when examining patients with respiratory symptoms.
Incorrect treatment due to misdiagnosis will have conse-
quences for the patients and for health economics, i.e.
adverse events attributable to ineffective asthma medica-
tion, the cost of asthma medications and emergency room
Dysfunctional breathing and breathing retraining 1159visits. DB can also occur in association with genuine asthma
and other airway diseases and there is a risk that these
patients are prescribed excessive doses of asthma
medication.
There were substantial improvements in the DB group
both in well known and validated instruments like the SF-36,
HADS and NQ and in the instruments made especially for this
study i.e. “Influence on daily life” (measured on a VAS) and
the “DB criterion list”. Values for minimal clinical changes
have been estimated for the PCS (SF-36)26 and VAS27 in other
therapeutic areas and these values were achieved in our
study. However, it has not been investigated whether these
values of minimal clinical changes apply to patients with DB.
This long-time follow-up study indicates that patients
with dysfunctional breathing benefit from learning about
their condition and from breathing retraining. As this is an
observational study, the results should be confirmed by
randomized controlled trials.
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